Dr. Maity is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1950 City of Hope Drive
Room 1570
Salt Lake City, UT 84112Phone+1 801-581-2396Fax+1 801-585-2666
Summary
- Dr. Amit Maity is a radiation oncologist in Salt Lake City, UT and works for University of Utah and the Huntsman Cancer Hospital. He received his medical degree from Boston University School of Medicine, then completed residencies in Internal Medicine at Mount Sinai Hospital in New York City and in Radiation Oncology at Hospital of the University of Pennsylvania followed by a PhD from the University of Pennsylvania. He has been in practice in radiation oncology for 35 years. He specializes in hematologic malignancies and is an active translational researcher.
Education & Training
- University of PennsylvaniaPhD, Pathology, 1992 - 1995
- University of Pennsylvania Health SystemResidency, Radiation Oncology, 1988 - 1991
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1985 - 1988
- Boston University School of MedicineClass of 1985
Certifications & Licensure
- UT State Medical License 2022 - 2026
- NJ State Medical License 1992 - 2023
- PA State Medical License 1988 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsLocal radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration.Nektarios Kostopoulos, Francesca Costabile, Elisavet Krimitza, Silvia Beghi, Denisa Goia
Blood Advances. 2024-12-24 - Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma.Jonathan A Baron, Christopher M Wright, Alexandra D Dreyfuss, Elise A Chong, Jakub Svoboda
Practical Radiation Oncology. 2024-07-04 - 1 citationsParkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance.Renzo Perales-Linares, Nektaria Maria Leli, Hesham Mohei, Silvia Beghi, Osvaldo D Rivera
Cancer Research. 2023-11-01
Abstracts/Posters
- A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell TherapyAmit Maity, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Concurrent Use of Novel Agents and Radiation Is Tolerated in Lymphoma PatientsAmit Maity, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Penn Scientists Aim to Bring Promising Cancer Therapy Closer to RealityMarch 2nd, 2022
- 5 Oncologists on the MoveJanuary 11th, 2022
- Error Reporting Improves Perceptions of Safety and May Reduce IncidentsOctober 30th, 2012
Grant Support
- Regulation Of Vegf/Hif-1 By AKT: Implications For RadiotherapyNational Cancer Institute2006–2010
- Regulation Of VEGF In Tumors By RAS, EGF And PTENNational Cancer Institute2002–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: